Kronos Bio, Inc.盘中异动急速上涨8.09%报0.935美元

市场透视11-27

北京时间2024年11月27日22时31分，Kronos Bio, Inc.（KRON.us）股票出现波动，股价急速拉升8.09%。截至发稿，该股报0.935美元/股，成交量14.1281万股，换手率0.23%，振幅1.73%。最近的财报数据显示，该股实现营业收入2.37百万美元，净利润-14.11百万美元，每股收益-0.23美元，毛利1.96百万美元，市盈率-0.65倍。机构评级方面，在所有3家...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2486820552?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2024-11-27 22:31","share_image_url":"https://static.laohu8.com/9a95c1376e76363c1401fee7d3717173","id":"2486820552","market":"us","top_or_hot":-1,"title":"Kronos Bio, Inc.盘中异动 急速上涨8.09%报0.935美元","media":"市场透视","content":"<div>\n<p>北京时间2024年11月27日22时31分，Kronos Bio, Inc.（KRON.us）股票出现波动，股价急速拉升8.09%。截至发稿，该股报0.935美元/股，成交量14.1281万股，换手率0.23%，振幅1.73%。最近的财报数据显示，该股实现营业收入2.37百万美元，净利润-14.11百万美元，每股收益-0.23美元，毛利1.96百万美元，市盈率-0.65倍。机构评级方面，在所有3家...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223106a259f141&s=b\">网页链接</a>\n\n</div>\n","source":"tencent","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Kronos Bio, Inc.盘中异动 急速上涨8.09%报0.935美元</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nKronos Bio, Inc.盘中异动 急速上涨8.09%报0.935美元\n</h2>\n\n<h4 class=\"meta\">\n\n\n2024-11-27 22:31 北京时间&nbsp;&nbsp;&nbsp;<a href=http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223106a259f141&s=b><strong>市场透视</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>北京时间2024年11月27日22时31分，Kronos Bio, Inc.（KRON.us）股票出现波动，股价急速拉升8.09%。截至发稿，该股报0.935美元/股，成交量14.1281万股，换手率0.23%，振幅1.73%。最近的财报数据显示，该股实现营业收入2.37百万美元，净利润-14.11百万美元，每股收益-0.23美元，毛利1.96百万美元，市盈率-0.65倍。机构评级方面，在所有3家...</p>\n\n<a href=\"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223106a259f141&s=b\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"BK4139","symbol_name":"生物科技","start_time":0,"source_url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223106a259f141&s=b","article_id":"2486820552","we_media_id":null,"thumbnails":[],"rights":{"source":"tencent","url":"http://gu.qq.com/resources/shy/news/detail-v2/index.html#/?id=nesSN20241127223106a259f141&s=b","rn_cache_url":null,"customStyle":"body{padding-top:10px;}#news_title{font-weight:bold;#titleStyle#;}#news_description span{font-size:12px;#descriptionStyle#;}.footer-note{#statement#}","selectors":".mod-LoadTzbdNews, body","filters":".relate-stock, .hot-list, .recom-box, .wx-sou","directOrigin":true},"url":"https://stock-news.laohu8.com/highlight/detail?id=2486820552","pubTimestamp":1732717866,"columns":[],"sourceInfo":{"source_id":"tencent","name":"腾讯"},"weMediaInfo":null,"summary":"北京时间2024年11月27日22时31分，Kronos Bio, Inc.股票出现波动，股价急速拉升8.09%。截至发稿，该股报0.935美元/股，成交量14.1281万股，换手率0.23%，振幅1.73%。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。","collect":0,"end_time":0,"defaultTopTitle":"qq.com","property":[],"viewcount":null,"language":"zh","relate_stocks":{"BK4139":"生物科技","KRON":"Kronos Bio, Inc.","BK4505":"高瓴资本持仓"},"translate_title":"Kronos Bio, Inc. surged 8.09% to $0.935 during the session","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"KRON":1},"content_text":"北京时间2024年11月27日22时31分，Kronos Bio, Inc.（KRON.us）股票出现波动，股价急速拉升8.09%。截至发稿，该股报0.935美元/股，成交量14.1281万股，换手率0.23%，振幅1.73%。最近的财报数据显示，该股实现营业收入2.37百万美元，净利润-14.11百万美元，每股收益-0.23美元，毛利1.96百万美元，市盈率-0.65倍。机构评级方面，在所有3家参与评级的机构中，33%的券商给予买入建议，67%的券商给予持有建议，无券商给予卖出建议。Kronos Bio, Inc.股票所在的生物技术行业中，整体涨幅为0.22%。其相关个股中，Celularity Inc C/Wts 16/07/2026 (To Pur Com)、Cyclerion Therapeutics, Inc.、Tuhura Biosciences, Inc.涨幅较大，Cyclerion Therapeutics, Inc.、Outlook Therapeutics, Inc.、Molecular Templates, Inc.较为活跃，换手率分别为776.44%、22.72%、6.71%，振幅较大的相关个股有Oragenics Inc.、Aim Immunotech Inc.、Inflarx N.V.，振幅分别为6.38%、6.22%、5.91%。Kronos Bio, Inc.公司简介：Kronos Bio Inc 是一家专注于发现和开发新型癌症治疗药物的临床阶段生物制药公司，旨在通过精准医学方案，通过靶向失调的转录来改变患者预后。该公司在一个业务部门运营，即生物制药产品的开发。（以上内容为腾讯自选股基于公开消息，由程序或算法智能生成，仅作为用户看盘参考，不作为投资建议或交易依据。股市有风险，请谨慎决策。）","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"","news_rank":0,"symbols":[],"gpt_button":1},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.29.3","shortVersion":"4.29.3","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2486820552"}

Kronos Bio, Inc.盘中异动 急速上涨8.09%报0.935美元

精彩评论

Kronos Bio, Inc.盘中异动急速上涨8.09%报0.935美元